Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of a non-invasive diagnostic platform designed for the early detection of cancer. Mursla Bio is based in Cambridge, United Kingdom and was founded in 2017. Its last reported valuation was $53.2 million in Apr 2025. It has raised $10.2 million.
Last reported valuation
$53.2M
Oct 2026
Priced at
—
Total raised
$10.2M
Last round
—
Cap table — not yet on record
Mursla Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Mursla Bio with a free Private Market View account
·Watch Mursla Bio: the Monday email on marks, rounds and moves
